Characterization of Pediatric Medical Conditions: Respiratory Syncytial Virus (RSV) Associated Illness

Basic Details
Date Posted
Wednesday, January 24, 2018
Health Outcome(s)
respiratory syncytial virus (RSV)

The goal of this query was to estimate the cohort size and baseline characteristics of seven groups of patients with evidence of respiratory syncytial virus (RSV). The cohorts are individuals with a diagnosis of RSV (any setting, inpatient, and outpatient, separately), a diagnosis of bronchiolitis, a diagnosis of RSV or bronchiolitis, prior dispensings of palivizumab, or who obtained a diagnostic assay for RSV (PCR +/- Antigen), among children aged 1 month to 5 years of age, in the Sentinel Distributed Database (SDD).

Additional Details
FDA Center
Time Period
January 1, 2008 - June 30, 2016
Study Type
Modular Program
Assessment Type
Exploratory Analyses
Population / Cohort
Individuals 60 months of age and younger
Data Sources
Sentinel Distributed Database (SDD)